Showing 3511-3520 of 20414 results for "".
Beauty Counter MD/New Products
https://reachmd.com/topics/skincare/beauty-counter-mdnew-products/35164/Expert insight on the hottest products, ingredients, and trends your patients are talking aboutDisaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
https://reachmd.com/programs/clinicians-roundtable/disaster-proofing-colorectal-cancer-screening-what-we-learned-from-covid-19/36480/Colorectal cancer screening saw significant disruptions during the COVID-19 pandemic, a challenge that has also been reflected during natural disasters such as hurricanes and wildfires. Dr. Gloria Coronado joins Dr. Charles Turck to discuss how these kinds of crises impact screening rates and how aTimely ATTR-CM Diagnosis: Addressing Social Determinants of Health
https://reachmd.com/programs/heart-matters/timely-attr-cm-diagnosis-addressing-social-determinants-of-health/36141/Understanding the impact of social determinants of health on transthyretin amyloid cardiomyopathy (ATTR-CM) diagnosis is essential to improving patient outcomes. Hear Dr. Kevin Alexander, an Assistant Professor of Medicine at Stanford University School of Medicine, break down how factors like povertAnalyzing Updates from the NCCN Guidelines for Colorectal Cancer Screening
https://reachmd.com/programs/clinicians-roundtable/analyzing-updates-from-the-nccn-guidelines-for-colorectal-cancer-screening/36481/The NCCN Guidelines for Colorectal Cancer Screening recently provided updates for patients at average and increased risk—most notably, lowering the recommended starting age from 50 to 45. Hear Dr. Reid Ness walk through the updates in depth, providing insight on screening protocols for different patEvaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
https://reachmd.com/programs/project-oncology/evaluating-gene-therapy-for-sickle-cell-disease-advantages-and-barriers/36234/Gene therapy is redefining the treatment landscape for sickle cell disease, with approaches like gene addition, gene editing, and fetal hemoglobin induction showing promise in reducing or even eliminating symptoms. However, while these therapies offer some advantages over allogeneic stem cell transpSjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
https://reachmd.com/programs/living-rheum/sjogrens-related-dry-eye-examining-targeted-treatment-strategies/36339/Sjögren’s-related dry eye requires intensive management, often combining lubrication with anti-inflammatory therapies and other interventions to reduce symptoms and improve quality of life. Join Dr. Michelle Hessen, Assistant Professor of Ophthalmology at the Wilmer Eye Institute and a member of theManagement of Poststroke Epilepsy: An Update
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/management-of-poststroke-epilepsy-an-update/32188/Poststroke seizure management is a clinical and research priority to improve prognosis.Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
https://reachmd.com/programs/heart-matters/understanding-lipid-and-lipoprotein-metabolism-in-cardiovascular-health/39734/Understanding how lipids and lipoproteins are formed, metabolized, and cleared is essential for accurate lipid interpretation and cardiovascular risk assessment. Hear from Dr. Robert Eckel as he explains these molecular mechanisms and implications for patient management. Dr. Eckel is a Professor EmeManaging Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
https://reachmd.com/programs/heart-matters/managing-cholesterol-and-triglyceride-levels-targeted-nutritional-approaches/37599/Effective lipid management depends on identifying how specific dietary factors drive LDL cholesterol and triglyceride elevations. Dr. Robert Eckel shares evidence-based strategies for tailoring nutrition recommendations in patients with hypercholesterolemia and hypertriglyceridemia. Dr. Eckel is a PFractional Micro-Coring for Weight Loss Laxity
https://reachmd.com/ma-issues-index/march-april-2026-issue/fractional-micro-coring-for-weight-loss-laxity/56631/Fractional excision for the removal of skin laxity